Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): a phase 2a randomized clinical trial
Extended titration Some researchers prefer a very gradual titration: increasing by 1.25 mg every 4 weeks instead of the standard 2.5 mg
10.1038/mp.2015.182 Mol
10.2174/0929867330666230223103524 2 AndrewsN
Medical Screening: Prior health assessments can help rule out contraindications like kidney, liver issues, or respiratory disorders
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
